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Abstract
Background: Hereditary defects of tooth dentin are classified into two main groups: dentin
dysplasia (DD) (types I and II) and dentinogenesis imperfecta (DGI) (types I, II, and III). Type II DGI
is one of the most common tooth defects with an autosomal dominant mode of inheritance. One
disease-causing gene, the dentin sialophosphoprotein (DSPP) gene, has been reported for type II
DGI.
Methods: In this study, we characterized a four-generation Chinese family with type II DGI that
consists of 18 living family members, including 8 affected individuals. Linkage analysis with
polymorphic markers D4S1534 and D4S414 that span the DSPP gene showed that the family is
linked to DSPP. All five exons and exon-intron boundaries of DSPP were sequenced in members of
type II DGI family.
Results: Direct DNA sequence analysis identified a novel mutation (c.49C→T, p.Pro17Ser) in
exon 1 of the DSPP gene. The mutation spot, the Pro17 residue, is the second amino acid of the
mature DSP protein, and highly conserved during evolution. The mutation was identified in all
affected individuals, but not in normal family members and 100 controls.
Conclusion: These results suggest that mutation p.Pro17Ser causes type II DGI in the Chinese
family. This study identifies a novel mutation in the DSPP gene, and expands the spectrum of
mutations that cause DGI.
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Background
Hereditary defects of tooth dentin include two types of
dentin dysplasia (DDI and DDII) and three types of den-
tinogenesis imperfecta (DGII, II and III). Dentinogenesis
imperfecta (DGI) is an autosomal dominant disorder
characterized by discolored teeth and often dislodged
enamel due to abnormal mineralization of the dentine of
the primary teeth [1,2]. The population prevalence rate of
DGI is estimated to be 1 in 6,000 to 8,000 individuals [3].
Type I DGI is the least severe and type III is the most severe
[1]. Type I DGI is associated with osteogenesis imperfecta,
whereas type II DGI and type III DGI are restricted to the
dentin.
To date, only one disease-causing gene, DSPP encoding
the dentin sialophosphoprotein, has been identified for
DGI [4]. The DSPP gene is located on human chromo-
some 4q21.3 and transcribed into one transcript which is
translated into the DSPP precursor protein [4]. The pre-
cursor is cleaved to form two mature proteins, dentin sia-
loprotein (DSP) and dentin phosphoprotein (DPP). DSP
and DPP are the major non-collagenous proteins of den-
tin expressed in teeth and bone [4]. DPP is rich in aspartic
acid and phosphoserine and binds to a large amount of
calcium. DSP is a glycoprotein rich in aspartic acid, serine,
glutamic acid and glycine [4-7]. Yamakoshi et al. has
established that DSP is a proteoglycan, and identified a
third domain, the dentin glycoprotein (DGP) domain of
DSPP [8,9].
The discovery of DSPP as the gene for type II DGI was
made in 2001 [10,11]. Several mutations have been
reported in DSPP. These mutations include five missense
mutations (p.Y6D, p.A15V, p.P17T, p.V18F, and
p.R68W), one nonsense mutation (p.Q45X), and three
splicing mutations (g.1188C→G; g.1275G→A;
g.1194C>A (IVS2-3)) [10-16]. Mutation p.Y6D was found
to be associated with type II dentin dysplasia (DD) [17],
this mutation is located in the signal peptide domain of
DSPP, and disabled the entry of DSPP into the endoplas-
mic reticulum [17]. Mutation p.V18F can cause both type
II and type III DGI. Mutation carriers with p.P17V and
p.V18F also presented with progressive sensorineural
high-frequency hearing loss [11]. The remaining muta-
tions described above cause type II DGI. One DSPP muta-
tion was found in a family with type III DGI (a compound
mutation consisting of a 36 bp deletion and 18 bp inser-
tion in exon 5) [18].
In this study, we identified and characterized a four-gen-
eration Chinese family with type II DGI with 18 living
family members and 8 affected individuals. We used link-
age analysis to map the disease-causing gene in the family
to the DSPP gene on chromosome 4q21.3, and further
studies identified a novel mutation (c.49C>T, p.Pro17Ser)
in DSPP in the family. Our finding suggests that Pro17 is
a mutational hotspot and it may be critical for the func-
tion of DSPP gene.
Methods
Study subjects and isolation of human genomic DNA
The study participants were identified and enrolled at
Luoyang Medical College. Detailed records on medical
history, clinical and radiographic features were obtained.
Informed written consent was obtained from the study
subjects. This study was approved by the ethics committee
of Huazhong University of Science and Technology.
Peripheral blood was collected from the participants.
Human genomic DNA was isolated from the whole blood
using the DNA Isolation Kit for Mammalian Blood
(Roche Diagnostic Co., Indianapolis, IN).
Linkage analysis
Two polymorphic microsatellite markers, D4S414  and
D4S1534  linked to DSPP, were selected from the ABI
PRISM Linkage Mapping Set-MD10 panel for linkage
analysis. Markers were genotyped using an ABI 3100
Genetic Analyzer at Huazhong University of Science and
Technology Center for Human Genome Research
(Applied Biosystems, Foster City, CA). Genotypes were
analyzed using the GeneMapper 2 Software program
(Applied Biosystems, Foster City, CA).
Mutation screening
Mutation screening was carried out using direct DNA
sequence analysis. All five DSPP exons including exon-
intron boundaries were PCR-amplified and sequenced.
The PCR primers for amplification of the DSPP exons and
exon-intron boundaries are:
exon 1 forward primer: 5'-TCACCAAGTGAAGGAAGTGG-
3'
reverse primer: 5'-AAAGCCCAAGGTGGATTTTT-3'
exon 2 forward primer: 5'-GATGTCCCCATAACCACACC-
3'
reverse primer: 5'-CTCCATGACTTCTGGGCATT-3'
exon 3 and 4 forward primer: 5'-CAAGCCCTGTAA-
GAAGCCACT-3'
reverse primer: 5'-ACATGGATGCTTGTCATGGT-3'
exon 5 forward primer: 5'-CCAGGATGCTTTCAATTA-
CAG-3'
reverse primer: 5'-CCCCCAGTTGTTTTTGTTTA-3'BMC Medical Genetics 2007, 8:52 http://www.biomedcentral.com/1471-2350/8/52
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PCR was performed in 25 μl of standard PCR buffer con-
taining 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.5 μM of
each primer, 1 unit of Taq DNA polymerase, and 25 ng of
human genomic DNA. The amplification program was
one cycle of 3 min for denaturation at 94°C, 35 cycles of
30 s at 94°C, 30 s at 65°C, 1 min at 72°C, and one 7 min
extension step at 72°C. The PCR products were purified
using the QIAquick Gel Extraction Kit (Qiagen Inc., Valen-
cia, CA), and sequenced with both forward and reverse
primers. DNA sequencing analysis was performed using
the BigDye Terminator Cycle Sequencing v3.1 kit and an
ABI PRISM 3100 Genetic Analyzer (Applied Biosystems,
Foster City, CA).
RFLP (restriction fragment length polymorphism) analysis
Mutation c.49C>T(p.Pro17Ser) disrupts a Bsr I restriction
site, which allowed us to perform RFLP analysis to con-
firm the mutation and to test whether the mutation co-
segregates with the disease in the family. Exon 1 of DSPP
containing the p.Pro17Ser mutation was PCR-amplified
from members of the family as well as 100 unrelated
healthy Chinese individuals. The 468 bp PCR product was
digested with 1 unit of Bsr I restriction enzyme (New Eng-
land Biolabs Inc, Ipswich, MA) at 65°C for overnight. The
digested products were separated and analyzed on a 2.0%
agarose gel.
Results
We identified a four-generation Chinese family with type
II DGI with 18 living family members and 8 affected indi-
viduals. The proband was a 28-year-old female (III-1 in
Fig. 1). At the age of 10-years, the enamel was lost through
attrition. Similar clinical features were detected in other 7
affected family members. The oral radiographs of the
affected son of the proband (IV:2 in Fig. 1) are shown in
Fig. 2.
To test whether the DSPP gene on chromosome 4q13-21
is the disease-causing gene in the family, we carried out
linkage analysis with two markers that span the DSPP
gene, D4S414 and D4S1534. As shown in Fig. 1, allele 1 of
D4S414 and allele 4 of D4S1534 co-segregate with the dis-
ease in the family. These results suggest that the disease
gene in the family is the DSPP gene.
Direct DNA sequence analysis of the DNA from the
proband revealed a heterozygous C→T transition at
nucleotide 49 of DSPP, which results in a substitution of
amino acid residue proline by a serine residue (Pro17Ser)
(Fig. 3A). The Pro17 residue of protein DSP is evolution-
arily conserved in homo sapiens, rattus norvegicus, mus mus-
culus, sus scrofa and bos taurus.
To confirm that the Pro17Ser mutation of DSPP is associ-
ated with the disease in the family, RFLP analysis was car-
a-b. Oral photographs from the affected individual (IV:2 in  Fig. 1) Figure 2
a-b. Oral photographs from the affected individual (IV:2 in 
Fig. 1). The primary teeth showed shade of brown and 
almost complete attrition of the enmel layer. c. Panorex radi-
ographs from the affected individual (IV:2 in Fig. 1).
Pedigree structure of a Chinese family affected with type II  DGI Figure 1
Pedigree structure of a Chinese family affected with type II 
DGI. Affected males and females are indicated by filled 
squares and circles, respectively. Normal individuals are 
shown as empty symbols. The proband is indicated by an 
arrow. Linkage analysis was performed with two polymor-
phic microsatellite markers, D4S414 and D4S1534 linked to 
the DSPP gene. Genotypic results are shown under each sym-
bol. Note that haplotype 1–4 co-segregates with affected 
individuals, suggesting that the disease-causing gene in the 
family is linked to DSPP.BMC Medical Genetics 2007, 8:52 http://www.biomedcentral.com/1471-2350/8/52
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ried out. The patients in the family showed the presence
of both wild type allele (268 bp and 200 bp bands) and
mutant allele (468 bp) (Fig. 4). RFLP analysis also showed
that the p.Pro17Ser mutation was not present in normal
family members (Fig. 4) and 100 normal controls (data
not shown). These results provide strong genetic evidence
that the pPro17Ser mutation of DSPP causes type II DGI
in the Chinese family.
Discussion
In this study, we identified a novel mutation,
c.49C>T(p.Pro17Ser), in the dentin sialophosphoprotein
gene (DSPP) in a Chinese family affected with dentino-
genesis imperfecta II (type II DGI). The p.Pro17Ser muta-
tion co-segregated with only affected individuals, and did
not exist in normal family members and 100 controls. The
Pro17 residue is highly conserved during evolution. These
results strongly suggest that the p.Pro17Ser mutation
causes type II DGI.
Interestingly, the Pro17 residue was mutated to a threo-
nine residue in a different DGI II family with five patients
[11]. In contrast to the family in this study, the affected
individuals with mutation p.Pro17Thr were also associ-
ated with bilateral progressive sensorineural high-fre-
quency hearing loss [11]. Together with the study by Xiao
et al., our study suggests that the Pro17 residue is a muta-
tion hot-spot that is critical to the function of DSPP gene.
Consistent with this conclusion, the Pro17 residue is con-
Mutation Pro17Ser of the DSPP gene co-segregated with type  II DGI in the family Figure 4
Mutation Pro17Ser of the DSPP gene co-segregated with type 
II DGI in the family. N, normal phenotype; P, affected pheno-
type; marker, molecular size standard. The lanes are labelled 
with the unique identification number for each individual in 
the Chinese family as in Fig. 1. The g.49C>T/Pro17Ser muta-
tion disrupts a BsrI restriction site. The wild type PCR prod-
uct can be cut by BsrI, yielding two DNA fragments of 268 bp 
and 200 bp. The PCR fragment containing mutation Pro17Ser 
cannot be cut by the enzyme, resulting in only one DNA frag-
ment of 468 bp. All affected individuals in the family are het-
erozygous for the Pro17Ser mutation (three fragments: 468 
bp, 268 bp and 200 bp). Normal family members display two 
268 bp and 200 bp bands.
Identification of a novel mutation, g.49C→T/(Pro17Ser), in  the DSPP gene in the Chinese family with type II DGI Figure 3
Identification of a novel mutation, g.49C→T/(Pro17Ser), in 
the DSPP gene in the Chinese family with type II DGI. a. DNA 
sequences for a normal family member (upper panel) and the 
proband III-1 (lower panel). The sequence of codon 17 
where the mutation occurs is boxed. The C to T change in 
the proband results in the substitution of a proline residue by 
a serine residue in the DSP protein. The predicted signal pep-
tide domain covers the first 15 amino acids, MKIITYFCI-
WAVAWA. The mature protein starts with the next 
isoleucine (I) residue. b. The alignment of amino acids in the 
N-terminal domain of DSPP from homo sapiens, sus scrofa, bos 
taurus, mus musculus, and rattus norvegious revealed that the 
Pro17 residue was highly conserved during evolution.BMC Medical Genetics 2007, 8:52 http://www.biomedcentral.com/1471-2350/8/52
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served in homo sapiens, rattus norvegicus, mus musculus, sus
scrofa and bos taurus.
The molecular mechanisms by which DSPP  mutations
cause DGI are not clear. Only one mutation, p.Y6D
located in the proposed hydrophobic signal peptide
domain, was biochemically characterized. Rajpar et al.
showed that the p.Y6D mutation blocked translocation of
the proteins encoded by DSPP into the endoplamic retic-
ulum(ER), suggesting that it is a loss-of-function muta-
tion [17]. The predicted signal peptide domain of DSP
spans the first 15 amino acid residues (MKIITYFCIWAVA-
WAIPVPQ). The Pro17 residue is only one amino acid res-
idue away from the signal peptide, thus Xiao et al.
proposed that the p.Pro17Thr mutation may interfere
with signal peptide cleavage [11]. Similarly, the
p.Pro17Ser mutation identified in this study may also
affect signal peptide cleavage, which may lead to reduced
translocation of DSPP to ER. One other possibility is that
the p.Pro17Ser mutation may affect pre-mRNA splicing of
DSPP as it is located at the exon 2/intron 2 boundary, and
changes a highly conserved C/A to T at the position of -3
of the 5'-splicing donor site. On the other hand, as the
Pro17 residue is the second amino acid residue in the
mature DSP protein, it may directly affect the biological
functions of DSP. These hypotheses remain to be tested
with functional studies.
Knockout mice deficient in DSPP showed dentin defects
that most closely resemble type III dentinogenesis imper-
fecta, which has more extreme abnormal dental pheno-
type that impacts beyond dentin to the enamele and the
pulps of affected teeth [19]. The Dspp-/- mice displayed the
phenotype of enlarged pulp chambers, increased width of
predentin zone, hypomineralization, and pulp exposure
[19]. Transgenic mice with over-expression of dentin sia-
loprotein and dentin phosphoprotein were created and
characterized [6]. Mice with over-expression of dentin sia-
loprotein showed an increased rate of enamel mineraliza-
tion. No significant defects in the enamel morphology
were observed. Mice with over-expression of dentin phos-
phoprotein showed defects in enamel structure with "pit-
ted" and "chalky" enamel of non-uniform thickness [6].
Thus, the knockout mice displayed the phenotype that
more closely resemble human DGI than the transgenic
overexpression mice, which supports the hypothesis that
the DSPP mutations may act by a loss-of-function mecha-
nism.
Conclusion
These results suggest that mutation p.Pro17Ser causes type
II DGI in the Chinese family. This study identifies a novel
mutation in the DSPP gene, and expands the spectrum of
mutations that cause DGI.
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